Follow on Google News News By Tag * Bone * Allograft * Orthobiologic * Tissue * Graft * Cell * Autologous * Osteotech * Biologics * Synthetic * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | "The Global Market for Orthobioligical Products" now available at Fast Market ResearchFast Market Research recommends "The Global Market for Orthobioligical Products" from Espicom Business Intelligence, now available
Other growth drivers include the rising numbers of obese patients with increasing levels of osteoarthritis and the resulting need for cartilage repair procedures. In addition, increasing numbers of patients have diabetes, which can lead to slower natural bone and soft tissue healing, and a greater number of people are participating in sports, leading to higher numbers of trauma and sport-related injuries. Safety concerns about bone morphogenetic protein (BMP)... BMP product sales have suffered from a July 2008 US Public Health Notification regarding complications associated with their use in the cervical spine. The off-label use of BMP products has also led to negative publicity regarding the products, as well as legal proceedings brought against the market leader, Medtronic. Stryker, the only other company with an FDA-approved growth factor, has also experienced setbacks with its products. In March 2009, the FDA's Orthopaedic and Rehabilitation Devices Advisory Panel voted not to recommend broad-based marketing approval for the use of Stryker's OP-1 for spinal fusion. In contrast, Medtronic is currently pursuing FDA approval for a new, higher-concentration BMP product, AMPLIFY. If approved, AMPLIFY could regenerate Medtronic's flagging BMP operations. In July 2010, the FDA's Orthopaedic and Rehabilitation Devices Advisory Panel gave a positive recommendation of AMPLIFY. ...has refocused interest on other technologies Synthetic bone graft substitutes have benefited from increased demand as a result of their lower cost compared with competing products, ease-of-use, ready availability and ease of storage. This led to an 18% increase in sales volumes during 2009. In addition, cell-based products, including autologous cartilage repair therapies, blood separation systems and bone marrow concentration systems, experienced 20% growth in 2009. However, this market is still in its infancy and was worth just US$180 million during the year. Growth for cell-based products is being driven by their clinical effectiveness, increased surgeon acceptance, and new product innovation in this sector. Human-derived products such as allograft and DBM each saw around 5% growth in 2009, to US$790 and US$575 million, respectively. While there continues to be increased demand, growth is somewhat hampered by a lack of availability, particularly in the case of allograft products. Medtronic acquires Osteotech - an ever changing competitive landscape As this report went to press, Medtronic announced it had agreed to acquire Osteotech, a leading competitor. While consolidating Medtronic's domination of the market, this development marks the latest corporate move to secure market share. Increasing interest from multi-nationals can be seen. For example, Baxter International made its formal entry into the biologics market by acquiring ApaTech, a UK-based company that has developed and markets innovative synthetic bone substitutes Providing... Sales forecasts for key orthobiologic sectors Market share for leading companies A review of the complex regulatory requirement in the US and EU Evaluation of key orthobiologic applications areas Detailed examination of product offerings by company for each sector Covering all major areas including... Allograft Demineralised bone matrix Synthetic bone grafts Soft tissue implants Growth factors Autologous platelet separation products Autologous bone marrow concentration products Autologous chondrocyte transplantation Stem cell therapy At-a-glance competitive comparisons for major and emerging companies aap Implantate AG Aastrom Biosciences Inc. Allograft Tissue systems AlloSource Alphatec Holdings Inc Anika Therapeutics Inc ApaTech Ltd Arteriocyte Medical Systems Inc Artimplant AB B Braun Melsungen AG Bacterin International Baxter International Inc Berkeley Advanced Biomaterials Inc. Biocomposites Ltd Biocoral Inc Biomatlante Sarl Biomet Inc. BioMimetic Therapeutics Biosafe Group SA Bone Biologics Inc Bone Solutions Inc BoneSupport AB Cardium Therapeutics Ceramisys Ltd Cerapedics Inc co.don AG Collagen Matrix Inc Community Tissue Services curasan AG Cytomedix Inc DePuy Inc. EmCyte Corp ETEX Corporation Exactech Inc. Fidia Advanced Biopolymers srl Geistlich Pharma AG GenOsteo Inc. Genzyme Biosurgery Geron Corp Graftys Harvest Technologies Corp Histogenics Corp Integra LifeSciences Interventional Spine Inc ISTO Technologies Inc Kasios Kensey Nash Corp Kinetic Concepts Inc Kuros Biosurgery AG Lanx Inc LifeNet Health Medtronic Inc. Merck Serono SA Mesoblast Ltd MiMedx Group Inc. Musculoskeletal Transplant Foundation Nanotherapeutics Inc NovaBone Products LLC NuVasive Inc Olympus Terumo Biomaterials Corp Orteq Bioengineering Orthofix International NV Orthox Ltd Osiris Therapeutics Inc Ossacur AG Osteotech Inc Pioneer Surgical Technology Parcell Laboratories PolyNovo Biomaterials Pty Ltd ProChon Biotech Ltd Progenteq Ltd For more information or to purchase this report, go to: - http://www.fastmr.com/ About Espicom Business Intelligence Espicom Business Intelligence is a highly-regarded and established provider of business intelligence services. Founded in 1982 as MDIS Publications Ltd, the company changed its name to Espicom in 1992. Initially a publisher in a wide range of industries such as power generation and telecommunications, they now focus on the global pharmaceutical and medical device sectors. View more research from Espicom Business Intelligence at http://www.fastmr.com/ About Fast Market Research Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156. # # # Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. End
|
| |||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number